ShRNA-mediated Bmi-1 silencing sensitizes multiple myeloma cells to bortezomib. [electronic resource]
Producer: 20150212Description: 616-23 p. digitalISSN:- 1791-244X
- Animals
- Apoptosis -- drug effects
- Boronic Acids -- administration & dosage
- Bortezomib
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Drug Resistance, Neoplasm -- genetics
- Gene Expression Regulation, Neoplastic
- Gene Silencing
- Humans
- Mice
- Mitogen-Activated Protein Kinase 7 -- antagonists & inhibitors
- Multiple Myeloma -- drug therapy
- Primary Cell Culture
- Pyrazines -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.